Thermo Fisher's PPD Unit Partners With AstraZeneca BioVentureHub To Advance R&D In Chromatography, Genomics, And Proteomics
Author: Benzinga Newsdesk | October 01, 2025 11:00am
The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden.
The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and strengthen the life science ecosystem. A dedicated team from Thermo Fisher will co-locate with AstraZeneca scientists to work on collaborative R&D projects with a focus initially on chromatography, molecular genomics and proteomics.
Posted In: AZN TMO